by Team Small News | Aug 31, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma, a leading pharmaceutical company, has received five observations from the US Food and Drug Administration (USFDA) for its facility in Telangana, India. The observations were made during a recent inspection of the facility, which is a key... by Team Small News | Aug 30, 2025 | Aurobindo Pharma, Pharma
The US Food and Drug Administration (FDA) has conducted an inspection of an active pharmaceutical ingredients (API) manufacturing facility owned by Apitoria Pharma, a subsidiary of Aurobindo Pharma. The facility, located in the Sangareddy district near Hyderabad, was...
by Team Small News | Aug 26, 2025 | Aurobindo Pharma, Cipla, Lupin, Pharma, Sun Pharma
The Saudi Arabia Generic Drugs Market is expected to grow significantly, reaching US$ 8.11 billion by 2033, with a Compound Annual Growth Rate (CAGR) of 8.02% from 2025 to 2033. This growth is attributed to increased healthcare needs, government efforts to reduce... by Team Small News | Jun 13, 2025 | Aurobindo Pharma, Pharma
On Thursday, a ceremony was held in Pydibhimavaram, Srikakulam district, to award certificates to 28 students who successfully completed a course on “Pharmaceutical Quality Control Analytical Techniques”. The certificates were handed over by K. Kamalakar... by Team Small News | Jun 6, 2025 | Aurobindo Pharma, Pfizer, Pharma
The US Food and Drug Administration (FDA) has granted approval to Aurobindo Pharma for its varenicline tablets, available in 0.5 mg and 1 mg strengths. This approval marks a significant milestone for Aurobindo, as its varenicline tablets are the generic equivalent of...
by Team Small News | May 22, 2025 | Aurobindo Pharma, Natco, Pharma, Piramal Pharma, Zydus
The Indian pharmaceutical sector has demonstrated robust growth over the past year, driven by a new trade agreement with the European Union that reduces tariffs on key drug exports. This agreement is expected to enhance India’s position as a global supplier of...